{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:38:12Z","timestamp":1792053492144,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cger.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:18:10Z","timestamp":1741594690000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Active Surveillance for Prostate Cancer in Older Men"],"prefix":"10.1016","volume":"41","author":[{"suffix":"II","given":"Matthew T.","family":"McLeay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cger.2025.01.004_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.cger.2025.01.004_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cger.2015.08.001","article-title":"Management of prostate cancer in the elderly","volume":"32","author":"Tay","year":"2016","journal-title":"Clin Geriatr Med"},{"issue":"7","key":"10.1016\/j.cger.2025.01.004_bib3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ijc.29538","article-title":"Prevalence of incidental prostate cancer: a systematic review of autopsy studies","volume":"137","author":"Bell","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.cger.2025.01.004_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.annepidem.2018.03.001","article-title":"Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014","volume":"28","author":"Li","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"41","key":"10.1016\/j.cger.2025.01.004_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity \u2014 United States, 2001\u20132017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"10.1016\/j.cger.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cger.2025.01.004_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.cger.2025.01.004_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer","volume":"370","author":"Bill-Axelson","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cger.2025.01.004_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.31015","article-title":"Long-term outcomes among men undergoing active surveillance for prostate cancer in Sweden","volume":"5","author":"Ventimiglia","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.cger.2025.01.004_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.6004\/jnccn.2021.0043","article-title":"NCCN Guidelines\u00ae insights: older adult oncology, version 1.2021","volume":"19","author":"Dotan","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cger.2025.01.004_bib12","first-page":"45","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.004_bib13","first-page":"869","article-title":"Predicting 15-year prostate cancer specific mortality after radical prostatectomy","volume":"185","author":"Eggener","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"23","key":"10.1016\/j.cger.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/jama.2018.11716","article-title":"Prostate cancer\u2013specific mortality across Gleason scores in black vs nonblack men","volume":"320","author":"Mahal","year":"2018","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.cger.2025.01.004_bib15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.cger.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/cncr.28600","article-title":"National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making","volume":"120","author":"Drazer","year":"2014","journal-title":"Cancer"},{"issue":"10071","key":"10.1016\/j.cger.2025.01.004_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cger.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.cger.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bju.13465","article-title":"Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients","volume":"119","author":"Washino","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.cger.2025.01.004_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s11845-024-03771-w","article-title":"Precision in prostate cancer detection: integrating prostate-specific antigen density (PSAD) and the Prostate Imaging Reporting and Data System (PI-RADS) to provide additional risk stratification for a more accurate diagnostic decision","author":"Hrub\u00e1","year":"2024","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.cger.2025.01.004_bib24","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part I: introduction, risk assessment, staging, and risk-based management","author":"Eastham","year":"2022","journal-title":"J\u00a0Urol"},{"issue":"30","key":"10.1016\/j.cger.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","article-title":"Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer","volume":"33","author":"Tosoian","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.004_bib27","first-page":"1147","article-title":"Factors associated with time to conversion from active surveillance to treatment for prostate cancer in a multi-institutional cohort","volume":"206","author":"Cooley","year":"2021","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.cger.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.eururo.2015.01.004","article-title":"Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer","volume":"67","author":"Simpkin","year":"2015","journal-title":"Eur Urol"},{"issue":"15","key":"10.1016\/j.cger.2025.01.004_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cger.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrurol.2015.313","article-title":"Active surveillance for prostate cancer: a narrative review of clinical guidelines","volume":"13","author":"Bruinsma","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"17","key":"10.1016\/j.cger.2025.01.004_bib31","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2009.25.7311","article-title":"Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program","volume":"28","author":"Ross","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.cger.2025.01.004_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.eururo.2018.01.017","article-title":"Refined analysis of prostate-specific antigen kinetics to predict prostate cancer active surveillance outcomes","volume":"74","author":"Cooperberg","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eururo.2019.10.007","article-title":"Randomized study of systematic biopsy versus magnetic resonance imaging and targeted and systematic biopsy in men on active surveillance (ASIST): 2-year postbiopsy follow-up","volume":"77","author":"Klotz","year":"2020","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.cger.2025.01.004_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.eururo.2019.12.009","article-title":"Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance","volume":"77","author":"Chesnut","year":"2020","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.eururo.2019.07.041","volume":"76","author":"Drost","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.004_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.cger.2025.01.004_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/iju.12634","article-title":"Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England","volume":"22","author":"Anastasiadis","year":"2015","journal-title":"Int J Urol"},{"issue":"24","key":"10.1016\/j.cger.2025.01.004_bib38","first-page":"02232-2","article-title":"PRECISE version 2: updated recommendations for reporting prostate magnetic resonance imaging in patients on active surveillance for prostate cancer","volume":"S0302-2838","author":"Englman","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.cger.2025.01.004_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.euros.2023.10.005","article-title":"Magnetic resonance imaging-guided active surveillance without annual rebiopsy in patients with grade group 1 or 2 prostate cancer: the prospective PROMM-AS study","volume":"59","author":"Valentin","year":"2024","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"10.1016\/j.cger.2025.01.004_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac071","article-title":"The association between financial toxicity and treatment regret in men with localized prostate cancer","volume":"6","author":"Joyce","year":"2022","journal-title":"JNCI Cancer Spectr"},{"issue":"6","key":"10.1016\/j.cger.2025.01.004_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14599","article-title":"Natural history of nonmetastatic prostate cancer managed with watchful waiting","volume":"7","author":"Ventimiglia","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.cger.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.eururo.2007.12.032","article-title":"Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891)","volume":"53","author":"Studer","year":"2008","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.cger.2025.01.004_bib43","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:44:36Z","timestamp":1752623076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069025000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0749069025000047"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2025.01.004","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active Surveillance for Prostate Cancer in Older Men","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}